title: Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine.
abstract: Soluble amyloid-β protein (Aβ) may cause cognitive impairment in Alzheimer's disease in the absence of significant neurodegeneration. Here, the ability of the NMDA receptor (NMDAR) antagonist memantine to prevent synthetic Aβ-mediated rapid functional deficits in learned behavior and synaptic plasticity was assessed in the rat. In vitro, pretreatment with a clinically relevant, NMDAR blocking concentration of memantine partially inhibited the induction of long-term potentiation (LTP) in the dentate gyrus and prevented further inhibition caused by exposure to Aβ(1-42). Whereas systemic injection with memantine alone inhibited LTP in the CA1 area in vivo, a subthreshold dose partially abrogated the inhibition of LTP by intracerebroventricular soluble Aβ(1-42). Similarly, systemic treatment with memantine alone impaired performance of an operant learning task and a subthreshold dose prevented the Aβ(1-42)-mediated increase in perseveration errors. The acute protection afforded by memantine, albeit in a narrow dose range, against the rapid disruptive effects of soluble Aβ(1-42) on synaptic plasticity and learned behavior strongly implicate NMDAR-dependent reversible dysfunction of synaptic mechanisms in Aβ-mediated cognitive impairment.
authors.affiliation: Department of Pharmacology and Therapeutics, Trinity College, Dublin 2, Ireland.
authors.forename: Igor
authors.initials: I
authors.lastname: Klyubin
authors.forename: Qinwen
authors.initials: Q
authors.lastname: Wang
authors.forename: Miranda N
authors.initials: MN
authors.lastname: Reed
authors.forename: Elaine A
authors.initials: EA
authors.lastname: Irving
authors.forename: Neil
authors.initials: N
authors.lastname: Upton
authors.forename: Jacki
authors.initials: J
authors.lastname: Hofmeister
authors.forename: James P
authors.initials: JP
authors.lastname: Cleary
authors.forename: Roger
authors.initials: R
authors.lastname: Anwyl
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Rowan
mesh_terms: D016229:Amyloid beta-Peptides / Q000494:pharmacology*; D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D004594:Electrophysiology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects; D006624:Hippocampus / Q000187:drug effects*; D007858:Learning / Q000187:drug effects*; D017774:Long-Term Potentiation / Q000187:drug effects*; D008297:Male; D008559:Memantine / Q000494:pharmacology*; D018696:Neuroprotective Agents / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D013569:Synapses / Q000187:drug effects*
chemical_list: D016229:Amyloid beta-Peptides; D018696:Neuroprotective Agents; D008559:Memantine